Clostridium difficile infection in Europe: A hospital-based survey

The Lancet

Volumn 377, Issue 9759, 2011, Pages 63-73

  Bauer, Martijn P ^a,b   Notermans, Daan W ^a   Van Benthem, Birgit Hb ^a   Brazier, Jon S ^c   Wilcox, Mark H ^d   Rupnik, Maja ^e   Monnet, Dominique L ^f   Van Dissel, Jaap T ^b   Kuijper, Ed J ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e Centre for Microbiology   (Slovenia)

^f EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLOSTRIDIUM TOXIN; COTRIMOXAZOLE; GLYCOPEPTIDE; LINCOSAMIDE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; EUROPE; FATALITY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SENESCENCE;

EID: 78650825355     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61266-4     Document Type: Article

References (39)

1. EJ Kuijper, B Coignard, P Tüll the ESCMID Study Group for Clostridium difficile (ESGCD) EU member states and the European Centre for Disease Prevention and Control (ECDC) Emergence of Clostridium difficile-associated disease in North America and Europe Clin Microbiol Infect 12 suppl 6 2006 2 18
2. CP Kelly, JT LaMont Clostridium difficile-more difficult than ever N Engl J Med 359 2008 1932 1940
3. M Warny, J Pepin, A Fang Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe Lancet 366 2005 1079 1084
4. LC McDonald, GE Killgore, A Thompson An epidemic, toxin gene-variant strain of Clostridium difficile N Engl J Med 353 2005 2433 2441
5. VG Loo, L Poirier, MA Miller A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality N Engl J Med 353 2005 2442 2449
6. M Rupnik, MH Wilcox, DN Gerding Clostridium difficile infection: new developments in epidemiology and pathogenesis Nat Rev Microbiol 7 2009 526 536
7. A Smith Outbreak of Clostridium difficile infection in an English hospital linked to hypertoxin-producing strains in Canada and the US Euro Surveill 10 2005 2735
8. EJ Kuijper, RJ van den Berg, S Debast Clostridium difficile ribotype 027, toxinotype III, the Netherlands Emerg Infect Dis 12 2006 827 830
9. EJ Kuijper, F Barbut, JS Brazier Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008 Euro Surveill 13 2008 18942
10. F Barbut, M Delmée, JS Brazier A European survey of diagnostic methods and testing protocols for Clostridium difficile Clin Microbiol Infect 9 2003 989 996
11. MP Bauer, EJ Kuijper, JT van Dissel European Society of Clinical Microbiology and Infectious Diseases European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI) Clin Microbiol Infect 15 2009 1067 1079
12. S Paltansing, RJ van den Berg, RA Guseinova, CE Visser, ER van der Vorm, EJ Kuijper Characteristics and incidence of Clostridium difficile-associated disease, The Netherlands, 2005 Clin Microbiol Infect 13 2007 1058 1064
13. P Bidet, V Lalande, B Salauze Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile J Clin Microbiol 38 2000 2484 2487
14. H Kato, N Kato, K Watanabe Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR J Clin Microbiol 36 1998 2178 2182
15. S Stubbs, M Rupnik, M Gibert, J Brazier, B Duerden, M Popoff Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile FEMS Microbiol Lett 186 2000 307 312
16. SL Stubbs, JS Brazier, GL O'Neill, BI Duerden PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes J Clin Microbiol 37 1999 461 463
17. M Rupnik, V Avesani, M Janc, C von Eichel-Streiber, M Delmée A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates J Clin Microbiol 36 1998 2240 2247
18. LC McDonald, B Coignard, E Dubberke, X Song, T Horan, PK Kutty the Ad Hoc Clostridium difficile Surveillance Working Group Recommendations for surveillance of Clostridium difficile-associated disease Infect Control Hosp Epidemiol 28 2007 140 145
19. WA Knaus, EA Draper, DP Wagner, JE Zimmerman APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829
20. G Maldonado, S Greenland Simulation study of confounder-selection strategies Am J Epidemiol 138 1993 923 936
21. F Barbut, P Mastrantonio, M Delmée, J Brazier, E Kuijper, I Poxton on behalf of the European Study Group on Clostridium difficile (ESGCD) Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates Clin Microbiol Infect 13 2007 1048 1057
22. O Lyytikäinen, H Turunen, R Sund Hospitalizations and deaths associated with Clostridium difficile infection, Finland, 1996-2004 Emerg Infect Dis 15 2009 761 765
23. L Søes, K Mølbak, S Strøbaek The emergence of Clostridium difficile PCR ribotype 027 in Denmark - a possible link with the increased consumption of fluoroquinolones and cephalosporins? Euro Surveill 14 2009 19176
24. P Soler, F Nogareda, R Cano Rates of Clostridium difficile infection in patients discharged from Spanish hospitals, 1997-2005 Infect Control Hosp Epidemiol 29 2008 887 889
25. RP Vonberg, F Schwab, P Gastmeier Clostridium difficile in discharged inpatients, Germany Emerg Infect Dis 13 2007 179 180
26. SB Debast, LA van Leengoed, A Goorhuis, C Harmanus, EJ Kuijper, AA Bergwerff Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans Environ Microbiol 11 2009 505 511
27. A Goorhuis, D Bakker, J Corver Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078 Clin Infect Dis 47 2008 1162 1170
28. S Alvarez-Perez, JL Blanco Prevalence of Clostridium difficile in diarrhoeic and non-diarrhoeic piglets Vet Microbiol 137 2009 302 305
29. JG Songer, HT Trinh, GE Killgore, AD Thompson, LC McDonald, BM Limbago Clostridium difficile in retail meat products, USA, 2007 Emerg InfectDis 15 2009 819 912
30. MA Jhung, AD Thompson, GE Killgore Toxinotype V Clostridium difficile in humans and food animals Emerg Infect Dis 14 2008 1039 1045
31. H Goossens, M Ferech, R Vander Stichele, M Elseviers ESAC Project Group Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet 365 2005 579 587
32. J Pépin, S Routhier, S Gagnon, I Brazeau Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada Clin Infect Dis 42 2006 758 764
33. TJ Henrich, D Krakower, A Bitton, DS Yokoe Clinical risk-factors for severe Clostridium difficile-associated disease Emerg InfectDis 15 2009 415 422
34. EA Sailhammer, K Carson, Y Chang Fulminant Clostridium difficile colitis. Patterns of care and predictors of mortality Arch Surg 144 2009 433 439
35. A Goorhuis, T Van der Kooi, N Vaessen Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands Clin Infect Dis 45 2007 695 703
36. F Sundram, A Guyot, I Carboo, S Green, M Lilaonitkul, A Scourfield Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors J Hosp Infect 72 2009 111 118
37. J Pépin, ME Alary, L Valiquette Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada Clin Infect Dis 40 2005 1591 1597
38. LV McFarland, GW Elmer, CM Surawicz Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease Am J Gastroenterol 97 2002 1769 1775
39. M Moshkowitz, E Ben-Baruch, Z Kline, Z Shimoni, M Niven, F Konikoff Risk factors for severity and relapse of pseudomembranous colitis in an elderly population Colorectal Dis 9 2007 173 177